BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21944866)

  • 21. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of IGFBP3 gene expression in short children born small for gestational age.
    Faienza MF; Marzano F; Ventura AM; Wasniewska M; Valenzise M; Valletti A; Caratozzolo MF; Cornacchia S; Sbisà E; Cavallo L; Tullo A
    Growth Horm IGF Res; 2011 Dec; 21(6):349-55. PubMed ID: 22001433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
    Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
    Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence.
    McElholm AR; McKnight AJ; Patterson CC; Johnston BT; Hardie LJ; Murray LJ;
    Gastroenterology; 2010 Jul; 139(1):204-12.e3. PubMed ID: 20403354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age.
    van der Kaay D; Deal C; de Kort S; Willemsen R; Leunissen R; Ester W; Paquette J; van Doorn J; Hokken-Koelega A
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1386-92. PubMed ID: 19158202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
    Meyer S; Schaefer S; Stolk L; Arp P; Uitterlinden AG; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Weise A; Pfützner A; Kann PH
    Pharmacogenomics; 2009 Oct; 10(10):1599-608. PubMed ID: 19842933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors.
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
    Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
    Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
    Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
    Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
    In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in the locus control region and promoter of GH1 are related to serum IGF-I levels and height in patients with isolated growth hormone deficiency and healthy controls.
    de Graaff LC; Argente J; van Meurs JB; Uitterlinden AG; Hokken-Koelega AC
    Horm Res Paediatr; 2010; 73(1):25-34. PubMed ID: 20190537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in candidate genes like the HMGA2 gene in the extremely tall.
    Hendriks AE; Brown MR; Boot AM; Oostra BA; Drop SL; Parks JS
    Horm Res Paediatr; 2011; 76(5):307-13. PubMed ID: 21921580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
    Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
    Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
    Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor-1 gene polymorphism in rheumatoid arthritis patients.
    Dhaunsi GS; Uppal SS; Haider MZ
    Scand J Rheumatol; 2012; 41(6):421-5. PubMed ID: 22839688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of growth hormone receptor gene expression in tall and short stature children.
    Pagani S; Radetti G; Meazza C; Bozzola M
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):427-430. PubMed ID: 28301320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
    Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
    Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.
    Meyer S; Schaefer S; Ivan D; Stolk L; Arp P; Uitterlinden AG; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Weise A; Pfützner A; Kann PH
    Pharmacogenomics; 2009 Feb; 10(2):293-302. PubMed ID: 19207031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.